Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 19, 2024
A case-control study of risk factors for incident hepatitis B virus infection in South African blood donorsUte Jentsch, Marion Vermeulen, Karin van den Berg, et al.Transfusion|August 18, 2017
Effect on gene expression of three allelic variants in GATA motifs of ABO, RHD, and RHCE regulatory elementsKatie Fennell, Roser Hoffman, Ken Yoshida, et al.Viruses|July 27, 2022
The Impact of Early Antiretroviral Treatment (ART) for HIV on the Sensitivity of the Latest Generation of Blood Screening and Point of Care AssaysMarion Vermeulen, Cari van Schalkwyk, Genevieve Jacobs, et al.The Journal of Infectious Diseases|April 6, 2019
Discovery of False Elite Controllers: HIV Antibody-Positive RNA-Negative Blood Donors Found To Be on Antiretroviral TherapyWendy Sykes, Karin Van den Berg, Genevieve Jacobs, et al.Journal of Clinical Microbiology|January 17, 2014
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TBAnne F Luetkemeyer, Michelle A Kendall, Xingye Wu, et al.Journal of Clinical Microbiology|February 27, 2009
Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settingsDean B Everett, Kathy Baisley, John Changalucha, et al.Journal of Clinical Microbiology|February 26, 2016
Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 SystemAnne-Marie Demers, Amour Venter, Sven O Friedrich, et al.Viruses|October 26, 2021
Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African ExperienceTanya Nadia Glatt, Caroline Hilton, Cynthia Nyoni, et al.Lancet (London, England)|September 21, 2010
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialSheena McCormack, Gita Ramjee, Anatoli Kamali, et al.Viruses|November 11, 2022
Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV InfectionKarin van den Berg, Marion Vermeulen, Sonia Bakkour, et al.Pageof 3